Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Effect of Behaviour Change Communication on Metabolic Syndrome and Its Markers among Ethiopian Adults: Randomized Controlled Trial

View through CrossRef
Abstract Background: Metabolic syndrome is a global public health problem affecting both developing and developed countries with major consequences on human health, social and economic development. In Ethiopia although there is an increase in the prevalence of metabolic Syndrome due to epidemiologic transition, there is no study that evaluated the effect of interventions. This study aimed to assess the effect of nutrition behaviour change communication on metabolic syndrome and its markers. Method: A individually randomized controlled trial was conducted among Ethiopian adults working in Jimma University from mid of September 2015 to December 30, 2015. A total of 224 participants were randomly allocated into intervention (n=112) and controls (n=112) groups. The list of administrative and academic staff involved in the baseline survey was used as a sampling frame. Data on socio-demographic, anthropometric, biochemical and clinical parameters were collected using trained data collectors. Difference in the differences in metabolic syndrome and its components between baseline and end line were compared by the intervention status. Multivariable logistic and linear regression models were used to isolate independent predictors of metabolic syndrome and its components, respectively. Results: Overall, there was significant difference (P<0.001) in the prevalence of metabolic syndrome between intervention (11.6%) and control groups (37.5%) on the end line survey. On multivariable logistic regression analyses, control groups were 8.5 times more likely to have metabolic syndrome compared to intervention groups (AOR=8.53, 95%CI: 3.60, 20.21, P <0.001). There was a significant mean difference in differences in most components of metabolic syndrome and other lipid profiles except HDL (P=0.717) in the intervention group. The mean difference in differences in waist circumference was 6.3 cm (P<0.001), while that of systolic blood pressure (BP) and diastolic BP were 6.1 mmHg (P< 0.001) and 3.6 mmHg (P=0.001), respectively. Likewise the difference of differences between intervention and control groups was 30.7 mg/dl (P<0.001) for T.Cholesterol, 55.5 mg/dl (P<0.001) for triglycerides, 21.9 mg/dl (P=0.015) for LDL and 22.2 mg/dl (P<0.001) for fasting blood sugar. Further multivariable linear regression analyses showed that after adjusting for many variables, there was a significant difference in difference between intervention groups in components of metabolic syndrome. For the intervention group the mean difference in differences was 6.1cm (β=6.1, P<0.001) for waist circumference and 4.2 mm Hg (β=4.2, P<0.05) for diastolic blood pressure and 6.5 mmHg (β=6.5, P<0.001) for systolic blood pressure compared with controls. Similarly, the mean difference in differences was higher in the intervention group by 19.9 mg/dl (β=19.9, P<0.05) for FBS, 57.5 mg/dl for TG (β=57.5, P<0.05), 24.40 mg/dl for LDL (β=24.4, P<0.05) and 30.9mg/dl for T.Cholestrol (β=30.9, P<0.001). This trial is retrospectively registered on Pan African Clinical Trial Registration with unique identification number of PACTR202003465339638. Conclusion: There was strong positive effect of behaviour change communication on metabolic syndrome and its components. The results imply the need for enhancing behaviour change interventions using various strategies at the community and health facility levels to curb the emerging burden of chronic non-communicable diseases in Ethiopia. Future research should examine the sustainability of such behaviour changes using a community based study.
Title: Effect of Behaviour Change Communication on Metabolic Syndrome and Its Markers among Ethiopian Adults: Randomized Controlled Trial
Description:
Abstract Background: Metabolic syndrome is a global public health problem affecting both developing and developed countries with major consequences on human health, social and economic development.
In Ethiopia although there is an increase in the prevalence of metabolic Syndrome due to epidemiologic transition, there is no study that evaluated the effect of interventions.
This study aimed to assess the effect of nutrition behaviour change communication on metabolic syndrome and its markers.
Method: A individually randomized controlled trial was conducted among Ethiopian adults working in Jimma University from mid of September 2015 to December 30, 2015.
A total of 224 participants were randomly allocated into intervention (n=112) and controls (n=112) groups.
The list of administrative and academic staff involved in the baseline survey was used as a sampling frame.
Data on socio-demographic, anthropometric, biochemical and clinical parameters were collected using trained data collectors.
Difference in the differences in metabolic syndrome and its components between baseline and end line were compared by the intervention status.
Multivariable logistic and linear regression models were used to isolate independent predictors of metabolic syndrome and its components, respectively.
Results: Overall, there was significant difference (P<0.
001) in the prevalence of metabolic syndrome between intervention (11.
6%) and control groups (37.
5%) on the end line survey.
On multivariable logistic regression analyses, control groups were 8.
5 times more likely to have metabolic syndrome compared to intervention groups (AOR=8.
53, 95%CI: 3.
60, 20.
21, P <0.
001).
There was a significant mean difference in differences in most components of metabolic syndrome and other lipid profiles except HDL (P=0.
717) in the intervention group.
The mean difference in differences in waist circumference was 6.
3 cm (P<0.
001), while that of systolic blood pressure (BP) and diastolic BP were 6.
1 mmHg (P< 0.
001) and 3.
6 mmHg (P=0.
001), respectively.
Likewise the difference of differences between intervention and control groups was 30.
7 mg/dl (P<0.
001) for T.
Cholesterol, 55.
5 mg/dl (P<0.
001) for triglycerides, 21.
9 mg/dl (P=0.
015) for LDL and 22.
2 mg/dl (P<0.
001) for fasting blood sugar.
Further multivariable linear regression analyses showed that after adjusting for many variables, there was a significant difference in difference between intervention groups in components of metabolic syndrome.
For the intervention group the mean difference in differences was 6.
1cm (β=6.
1, P<0.
001) for waist circumference and 4.
2 mm Hg (β=4.
2, P<0.
05) for diastolic blood pressure and 6.
5 mmHg (β=6.
5, P<0.
001) for systolic blood pressure compared with controls.
Similarly, the mean difference in differences was higher in the intervention group by 19.
9 mg/dl (β=19.
9, P<0.
05) for FBS, 57.
5 mg/dl for TG (β=57.
5, P<0.
05), 24.
40 mg/dl for LDL (β=24.
4, P<0.
05) and 30.
9mg/dl for T.
Cholestrol (β=30.
9, P<0.
001).
This trial is retrospectively registered on Pan African Clinical Trial Registration with unique identification number of PACTR202003465339638.
Conclusion: There was strong positive effect of behaviour change communication on metabolic syndrome and its components.
The results imply the need for enhancing behaviour change interventions using various strategies at the community and health facility levels to curb the emerging burden of chronic non-communicable diseases in Ethiopia.
Future research should examine the sustainability of such behaviour changes using a community based study.

Related Results

Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Effect of Behaviour Change Communication on Metabolic Syndrome and Its Markers among Ethiopian Adults: Randomized Controlled Trial
Effect of Behaviour Change Communication on Metabolic Syndrome and Its Markers among Ethiopian Adults: Randomized Controlled Trial
Abstract Background: Metabolic syndrome (MetS) is a global public health problem with dire consequences on health, social and economic development. In Ethiopia although Met...
Determinants of Metabolic Syndrome among Malaysian Government Employees
Determinants of Metabolic Syndrome among Malaysian Government Employees
Introduction: The metabolic syndrome comprises a collection of cardiovascular disease risks, which has been demonstrated to predict type 2 diabetes mellitus and cardiovascular dise...
Metabolic syndrome and neuroprotection
Metabolic syndrome and neuroprotection
Introduction: over the years, the prevalence of metabolic syndrome has increased dramatically in developing countries as a major by-product of industrialization. Many factors, such...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Parent Training Interventions for Attention Deficity Hyperactivity Disorder (ADHD) in Children Aged 5 to 18 years
Parent Training Interventions for Attention Deficity Hyperactivity Disorder (ADHD) in Children Aged 5 to 18 years
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder. For a child to be diagnosed with ADHD, adults such as parents, carers, healthcare workers or teach...
The Canberra Bubble
The Canberra Bubble
According to the ABC television program Four Corners, “Parliament House in Canberra is a hotbed of political intrigue and high tension … . It’s known as the ‘Canberra Bubble’ and i...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...

Back to Top